Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
6,638,753
-
Share change
-
-24,418
-
Total reported value
-
$159,861,000
-
Put/Call ratio
-
175%
-
Price per share
-
$24.08
-
Number of holders
-
38
-
Value change
-
-$772,505
-
Number of buys
-
14
-
Number of sells
-
15
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q3 2016
As of 30 Sep 2016,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,638,753 shares.
The largest 10 holders included
FMR LLC, Cormorant Asset Management, LLC, ORBIMED ADVISORS LLC, Tekla Capital Management LLC, LAZARD ASSET MANAGEMENT LLC, FRANKLIN RESOURCES INC, MILLENNIUM MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Clough Capital Partners L P, and Artal Group S.A..
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.